 E31 |
 |
Polyglandular dysfunction  |
| |
| Excludes1 |
ataxia telangiectasia [Louis-Bar] (G11.3)
dystrophia myotonica [Steinert] (G71.11)
pseudohypoparathyroidism (E20.1)
|
|
| |
 E31.0 |
|
Autoimmune polyglandular failure |
| |
|
|
| |
| E31.1 |
|
Polyglandular hyperfunction |
| |
| Excludes1 |
multiple endocrine adenomatosis (E31.2-)
multiple endocrine neoplasia (E31.2-)
|
|
|
| |
| E31.2 |
|
Multiple endocrine neoplasia [MEN] syndromes |
| |
| Multiple endocrine adenomatosis |
| CodeAlso |
any associated malignancies and other conditions associated with the syndromes
|
|
| |
| E31.20 |
|
Multiple endocrine neoplasia [MEN] syndrome, unspecified |
| |
| Multiple endocrine adenomatosis NOS | | Multiple endocrine neoplasia [MEN] syndrome NOS |
|
| | |
| E31.21 |
|
Multiple endocrine neoplasia [MEN] type I |
| |
|
| | |
| E31.22 |
|
Multiple endocrine neoplasia [MEN] type IIA |
| |
|
| | |
| E31.23 |
|
Multiple endocrine neoplasia [MEN] type IIB |
| |
| |
| E31.8 |
|
Other polyglandular dysfunction |
|
| |
| E31.9 |
|
Polyglandular dysfunction, unspecified |
|